GXMC
VNDA icon

Global X Management Company’s Vanda Pharmaceuticals VNDA Stock Holding History

Global X Management Company’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,328
Closed -$17K – 1011
2015
Q2 		$17K Sell
1,328
-503
-27% -$5.42K ﹤0.01% 503
2015
Q1 		$17K Buy
+1,831
New +$20.7K ﹤0.01% 516
2014
Q4 		– Sell
-1,784
Closed -$19K – 575
2014
Q3 		$19K Sell
1,784
-367
-17% -$4.81K ﹤0.01% 480
2014
Q2 		$35K Buy
+2,151
New +$28.6K ﹤0.01% 377

Other funds holding VNDA

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Global X Management Company's VNDA Position: Q3 2015 in Review

Global X Management Company sold out of Vanda Pharmaceuticals (VNDA) in Q3 2015, closing a stake of 1,328 shares — an estimated $17K sold.

Global X Management Company first reported a position in VNDA in Q2 2014 and held it in 4 quarters. The position peaked at $35K in Q2 2014. 122 funds tracked by Wall St. Rank hold VNDA as of Q3 2015.

  • Global X Management Company reported no remaining Vanda Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Global X Management Company sold 1,328 Vanda Pharmaceuticals shares in Q3 2015, an estimated $17K.
  • Global X Management Company first reported a position in Vanda Pharmaceuticals in Q2 2014 and held it in 4 quarters.
  • Global X Management Company's Vanda Pharmaceuticals position peaked at $35K in Q2 2014.
  • 122 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2015.

Based on Global X Management Company's 13F filing for Q3 2015, filed 12 Nov 2015.